You are already at the latest version Cocaine use disorder (CUD) remains a significant global health issue, with no FDA-approved pharmacological treatments. Cannabidiol (CBD), a non-psychoactive phytocannabinoid primarily derived from Cannabis sativa L., has demonstrated promising results in preclinical research to disrupt the consolidation and retrieval of drug-associated memories, thereby reducing relapse behaviors linked to substance use disorders such as cocaine dependence.